- Dr. Ankur Bahl
- Speciality: Oncology
- Designation: Medical Oncology, Senior Director
- Education: MBBS, MD – Medicine, DM – Medical Oncology
- Experience: 20+ years
- Fortis Hospital Gurgaon
About Dr. Ankur Bahl
Dr. Ankur Bahl is a renowned cancer specialist with over 20 years of extensive experience in medical oncology. He earned his MBBS and MD in Medicine from Maulana Azad Medical College, Delhi. Furthermore, he completed his specialized training in Medical Oncology at the prestigious All India Institute of Medical Sciences (AIIMS), New Delhi. Additionally, Dr. Bahl underwent advanced training at the University of Oxford, UK, focusing on adverse drug reactions, drug interactions, and pharmacovigilance. This training further enhances his expertise in oncology.
Moreover, his clinical proficiency includes supportive and palliative care, hormone therapy, targeted therapies, and cutting-edge immunotherapy. He has significantly advanced cancer care in India. Notably, he serves as the primary author of pivotal research on the treatment of acute myeloid leukemia, human papillomavirus patterns in the Indian population, and targeted therapies for head and neck cancer. In addition, he is a key founder of several innovative national and international cancer educational networks, including oncology master classes, workshops, live tumor boards, and evidence-based discussions.
Dr. Bahl’s professional journey includes notable positions, such as Director of Medical Oncology and Hematology Oncology at Max Hospital, Saket. Currently, he practices at Fortis Memorial Research Institute (FMRI) in Gurugram. His prior affiliations include the Rajiv Gandhi Cancer Institute and Research Centre and Maulana Azad Medical College.
Education & Credentials
- MBBS: G B Pant Hospital / Maulana Azad Medical College, New Delhi
- MD (Medicine): G B Pant Hospital / Maulana Azad Medical College, New Delhi
- DM (Medical Oncology): All India Institute of Medical Sciences (AIIMS), New Delhi
Key Achievements
- Clinical Expertise: Extensive experience in supportive and palliative care, hormone therapy, targeted therapies, and immunotherapy.
- Research Contributions: Lead author of significant studies on acute myeloid leukemia treatment, human papillomavirus patterns, and targeted therapy for head and neck cancer.
- Educational Leadership: Founder of national and international cancer educational networks, including oncology master classes and live tumor boards.
- Professional Affiliations: Member of the American Society of Clinical Oncology (ASCO), European Society of Medical Oncology (ESMO), and Indian Society of Medical and Paediatric Oncology (ISMPO).
- Previous Roles: Director of Medical Oncology and Hematology Oncology at Max Hospital, Saket; affiliations with the Rajiv Gandhi Cancer Institute and Research Centre and Maulana Azad Medical College.
- Advanced Training: Completed a course on adverse drug reactions, drug interactions, and pharmacovigilance at the University of Oxford, UK.
In conclusion, Dr. Ankur Bahl’s dedication to advancing cancer care, extensive clinical expertise, and commitment to education make him a leading authority in medical oncology in Gurugram, India.
